Switch to:

Ocular Therapeutix Inc (OCUL) Ownership Data

Short Interest History (%)

This is the historical short interest of Ocular Therapeutix Inc, as measured by the Short Percentage Of Float.

Date Short Interest
August 31, 201632.85
August 15, 201628.22
July 29, 201621.52
July 15, 201622.49
June 30, 201618.18
June 15, 201617.87
May 31, 201621.62
May 13, 201623.37
April 29, 201622.26
April 15, 201623.84
March 31, 201623.71
March 15, 201621.13
February 29, 201623.29
February 12, 201620.27
January 29, 201618.32
January 15, 201617.95
December 31, 201516.59
December 15, 201517.01
November 30, 201519.02
November 13, 201520.77
October 30, 201519.04
October 15, 201517.87
September 30, 201517.27
September 15, 201514.46
August 31, 201512.95
August 14, 201511.18
July 31, 20158.17
July 15, 20157.97
June 30, 20156.52
June 15, 20156.14
May 29, 20158.44
May 15, 20157.89
April 30, 20158.27
April 15, 20158
March 31, 20155.27
March 13, 20155.94
February 27, 20153.26
February 13, 20153.79
January 30, 20154.33
January 15, 20153.89
December 31, 20143.33
December 15, 20142.99
November 28, 20143.28
November 14, 20143.12
October 31, 20142.97
October 15, 20142.97
September 30, 20141.24
September 15, 20140.58
August 29, 20140.49
August 15, 20140.3
July 31, 20140.11

Institutional Ownership History (%)

This the Institutional Ownership History of Ocular Therapeutix IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
June 30, 201677.47
March 31, 201683.63
June 30, 201573.23
March 31, 201562.78
December 31, 201472.76
September 30, 201435.33

Insider ownership (%)

This is the historical insider ownership of Ocular Therapeutix Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
August 31, 20163.49
July 31, 20163.26
June 30, 20163.26
May 31, 20163.22
April 30, 20163.22
March 31, 20163.22
February 29, 20163.23
January 31, 20163.23
December 31, 20153.22
November 30, 20153.23
October 31, 20153.19
September 30, 20153.19
August 31, 20153.08
July 31, 20153.08
June 30, 20153.08
May 31, 20153.08
April 30, 20152.85
March 31, 20152.85
February 28, 20152.74
January 31, 20152.37
November 30, 20142.37
October 31, 20142.37
September 30, 20142.37
August 31, 20142.37
July 31, 20142.46

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Amarpreet Sawhney, PhDPresident and CEO, 10% Owner632,0902.55%2016-08-05
Mr. James FortuneN/A112,0600.45%2015-09-15
Mr. Eric AnkerudN/A78,6510.32%2014-07-30
Dr. Richard L. Lindstrom,M.D.N/A43,5590.18%2015-02-27

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus3,711,5522016-06-3014.95N/A18,372
Jennison Associates LLC   Premium Plus2,972,6062016-06-3011.980.0214,714
Versant Venture Management LLC   Premium Plus2,215,3842016-06-308.9311.1110,966
Versant Ventures III, LLC2,215,3842015-12-318.95N/A20,758
SV Life Sciences Advisers, LLC   Premium Plus1,932,6072016-06-307.799.669,566
SVLSF IV LLC1,932,6072015-12-317.81N/A18,109
Prudential Jennison Health Sciences Fund1,670,5762016-08-316.730.4710,675
Fidelity® Independence Fund1,619,8532016-07-316.530.197,079
Fidelity® Select Biotechnology Portfolio1,531,1282016-07-316.170.066,691
Federated Kaufmann Fund1,199,1662016-06-304.830.125,936

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK